Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000465731 | SCV000562520 | benign | Tuberous sclerosis 1 | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000575849 | SCV000675378 | likely benign | Hereditary cancer-predisposing syndrome | 2017-02-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001696911 | SCV000719070 | likely benign | not provided | 2021-02-26 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000465731 | SCV002040425 | benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000575849 | SCV002530921 | benign | Hereditary cancer-predisposing syndrome | 2021-10-30 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002496842 | SCV002808206 | likely benign | Lymphangiomyomatosis; Tuberous sclerosis 1; Isolated focal cortical dysplasia type II | 2021-12-23 | criteria provided, single submitter | clinical testing |